Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
This trial is conducted in Europe. The aim of this trial is to evaluate the efficacy and safety of biphasic insulin aspart 30 in subjects with type 1 or type 2 diabetes.
Epistemonikos ID: 5b28fe79dba7bf6fdc3626f2916e6f30ed28891f
First added on: May 10, 2024